Prosecution Insights
Last updated: May 04, 2026
Application No. 17/834,342

PATIENT SUPPORT APPARATUSES WITH DYNAMIC CONTROL PANELS

Non-Final OA §DP
Filed
Jun 07, 2022
Priority
Jun 05, 2015 — provisional 62/171,472 +2 more
Examiner
SANTOS, ROBERT G
Art Unit
3673
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Stryker Corporation
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
827 granted / 1139 resolved
+20.6% vs TC avg
Strong +36% interview lift
Without
With
+35.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
22 currently pending
Career history
1161
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
40.1%
+0.1% vs TC avg
§102
33.2%
-6.8% vs TC avg
§112
10.4%
-29.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1139 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 15-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on October 23, 2025. Specification The disclosure is objected to because of the following informalities: 1) On page 1, in paragraph 0001, line 3: The phrase --now U.S. Patent No. 11,351,074,-- should be inserted after the phrase “WITH DYNAMICAL CONTROL PANELS,”. 2) On page 1, in paragraph 0001, line 5: The phrase --now U.S. Patent No. 10,420,688,-- should be inserted after the phrase “APPARATUSES WITH DYNAMIC CONTROL PANELS,”. Appropriate correction is required. Claim Objections Claim 14 is objected to because of the following informalities: In the second line of claim 14, the term --the-- should be inserted before the term “control”. Appropriate correction is required. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); and In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-14 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 7-19 of U.S. Patent No. 11,351,074. Although the claims at issue are not identical, they are not patentably distinct from each other because claims 1-14 are generic to all that is recited in claims 1 and 7-19 of U.S. Patent No. 11,351,074. In other words, claims 1 and 7-19 of U.S. Patent No. 11,351,074 fully encompass the subject matter of claims 1-14 and therefore anticipate claims 1-14. Since claims 1-14 are anticipated by claims 1 and 7-19 of the patent, they are not patentably distinct from claims 1 and 7-19. Thus the invention of claims 1 and 7-19 of the patent is in effect a “species” of the “generic” invention of claims 1-14. It has been held that the generic invention is anticipated by the species, see In re Goodman, 29 USPQ2d 2010 (Fed. Cir. 1993). Since claims 1-14 are anticipated (fully encompassed) by claims 1 and 7-19 of the patent, claims 1-14 are not patentably distinct from claims 1 and 7-19, regardless of any additional subject matter present in claims 1 and 7-19. Conclusion The prior art made of record and not relied upon is considered pertinent to Applicant's disclosure: Hosokawa et al. ‘071, Furman et al. ‘444, Furman et al. ‘587, Hosokawa et al. ‘039, Furman et al. ‘688, Furman et al. ‘263, Hough et al. ‘890, Elliot et al. ‘217, Blanchard et al. ‘271, Kappeler et al. ‘582, Poulos et al. ‘494, Poulos et al. ‘555 and Williams et al. ‘138. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT G SANTOS whose telephone number is (571)272-7048. The examiner can normally be reached Monday-Friday 9am-11:30am and 2pm-7:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, Applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Justin C Mikowski can be reached at 571-272-8525. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROBERT G SANTOS/Primary Examiner, Art Unit 3673
Read full office action

Prosecution Timeline

Jun 07, 2022
Application Filed
Feb 07, 2026
Non-Final Rejection — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12611345
PATIENT SUPPORT WITH IMPROVED CONTROL
4y 4m to grant Granted Apr 28, 2026
Patent 12604993
POCKETED SPRING ASSEMBLY INCLUDING CUSHION PADS AND BUCKLING MEMBERS WITH ADDITIVES
2y 1m to grant Granted Apr 21, 2026
Patent 12599517
STRETCHER EQUIPPED WITH SYSTEMS FOR ATTACHING REMOVABLE MEDICAL EQUIPMENT
3y 0m to grant Granted Apr 14, 2026
Patent 12599256
LIGHTWEIGHT SLEEPING PAD SYSTEM HAVING SEPARABLE AND DISSIMILAR SEGMENTS, AND METHOD OF USING
2y 4m to grant Granted Apr 14, 2026
Patent 12593930
POCKETED FOAM FILLED BUCKLING MEMBER ASSEMBLY
1y 7m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+35.8%)
2y 3m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1139 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month